Setting Safe Acute Exposure Limits for Halon Replacement Chemicals Using Physiologically Based Pharmacokinetic Modeling (original) (raw)
Pharmacokinetics of Halothane in man: A novel approach
Й Й
1971
View PDFchevron_right
Validation and Application of Pharmacokinetic Models for Interspecies Extrapolations in Toxicity Risk Assessments of Volatile Organics
Srinivasa Muralidhara
1989
View PDFchevron_right
Halothane Biotransformation in Man
David J H Blake
Annals of the New York Academy of Sciences, 1971
View PDFchevron_right
Modeling the tissue solubilities and metabolic rate constant (Vmax) of halogenated methanes, ethanes, and ethylenes
Martin Andersen
Toxicology Letters, 1988
View PDFchevron_right
DEVELOPMENT AND APPLICATION OF A GENERALIZED PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR MULTIPLE ENVIRONMENTAL CONTAMINANTS
Ian Cousins
Environmental Toxicology and Chemistry, 2003
View PDFchevron_right
PBTK model for assessment of operator exposure to haloxyfop using human biomonitoring and toxicokinetic data
Alistair Morriss
Regulatory Toxicology and Pharmacology, 2018
View PDFchevron_right
Pharmacokinetics of halogenated ethylenes in rats
Johannes G Filser
Archives of Toxicology, 1979
View PDFchevron_right
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment
David Morgott
Environmental Health Perspectives, 2000
View PDFchevron_right
Interspecies extrapolations of halocarbon respiratory and tissue kinetics: applications to predicting toxicity in different species
Randall Tackett
1994
View PDFchevron_right
Validation of a Physiological Modeling Framework for Simulating the Toxicokinetics of Chemicals in Mixtures
Kannan krishnan
Toxicology and Applied Pharmacology, 2000
View PDFchevron_right
MECHANISMS OF CARDIAC SENSITIZATION DUE TO INHALATION OF HALOGENATED GASES
Juan Vitali (Office of Science And Technology- The White House)
View PDFchevron_right
Duration Adjustment of Acute Exposure Guideline Level Values for Trichloroethylene Using a Physiologically-Based Pharmacokinetic Model
William Boyes
Risk Analysis, 2005
View PDFchevron_right
Assessing Human Variability in Kinetics for Exposures to Multiple Environmental Chemicals: A Physiologically Based Pharmacokinetic Modeling Case Study with Dichloromethane, Benzene, Toluene, Ethylbenzene, and m-Xylene
Mathieu Valcke, Sami Haddad
Http Dx Doi Org 10 1080 15287394 2014 971477, 2015
View PDFchevron_right
Development and specification of physiologically based pharmacokinetic models for use in risk assessment
Rebecca Clewell
Regulatory Toxicology and Pharmacology, 2008
View PDFchevron_right
Subcellular binding of halothane-1-14C in mouse liver and brain
David J H Blake
Journal of Pharmaceutical Sciences, 1973
View PDFchevron_right
Myocardial Effects of Halothane and Isoflurane in Senescent Rats
Benoît Vivien
Anesthesiology, 2002
View PDFchevron_right
Effect of halothane on myocardial infarct size in rats
Jerry Reves
Canadian Anaesthetists’ Society Journal, 1981
View PDFchevron_right
Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation
Hollie Swanson
Toxicological sciences : an official journal of the Society of Toxicology, 2001
View PDFchevron_right
Comparison of the Use of a Physiologically Based Pharmacokinetic Model and a Classical Pharmacokinetic Model for Dioxin Exposure Assessments
Claude Emond
Environmental Health Perspectives, 2005
View PDFchevron_right
Stereoselective halofantrine disposition and effect:concentration-related QTc prolongation
Jean Barbey
British Journal of Clinical Pharmacology, 2001
View PDFchevron_right
Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids
Thomas Osimitz
Toxicological Sciences, 2020
View PDFchevron_right
Evaluation of physiologically based pharmacokinetic models for use in risk assessment
Kannan krishnan
Journal of Applied Toxicology, 2007
View PDFchevron_right
Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base
Martin Danis
Malaria journal, 2009
View PDFchevron_right
Combining physiologically based pharmacokinetic modeling with Monte Carlo simulation to derive an acute inhalation guidance value for trichloroethylene
Ted Simon
1997
View PDFchevron_right
Hormonal and Hemodynamic Responses to Halothane and Enflurane in Spontaneously Hypertensive Rats
John Althaus
Anesthesia & Analgesia, 1985
View PDFchevron_right
Studies on the mechanism of haloacetonitriles toxicity: quantitative whole body autoradiographic distribution of [2-14C]chloroacetonitrile in rats
SAM JACOB
Toxicology, 1991
View PDFchevron_right
Minimum alveolar concentration of halogenated volatile anaesthetics in left ventricular hypertrophy and congestive heart failure in rats
Morgan Le Guen
British Journal of Anaesthesia, 2007
View PDFchevron_right
Blood/gas partition coefficients of halothane, isoflurane and sevoflurane in horse blood
Alessandra Bergadano
British Journal of Anaesthesia, 2003
View PDFchevron_right
Isoflurane Does Not Prevent Hepatic Injury Produced by Halothane in Rats
Argyro Fassoulaki
Anesthesia & Analgesia, 1984
View PDFchevron_right
Halofantrine Safety, Tolerance and Metabolism Studies
Jean Barbey
1997
View PDFchevron_right
Effect of halothane, enflurane and isoflurane on the end-systolic pressure-length relationship
Pieter R Fourie
Canadian Journal of Anaesthesia-journal Canadien D Anesthesie, 1987
View PDFchevron_right
A possible mechanism of halocarbon-induced cardiac sensitization arrhythmias
Samuel Dudley
Journal of Molecular and Cellular Cardiology, 2006
View PDFchevron_right